Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax Reconfirms Confidence in Regulatory Filing Timelines and Manufacturing Quality
- Statement
- COVID-19
Oct 20, 2021
Novavax Statement on Initial Com-COV2 Phase 2 Clinical Trial Results Presented at World Vaccine Congress Europe
- Statement
- COVID-19
Oct 19, 2021
Novavax to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights on November 4, 2021
- Corporate and Finance
Oct 18, 2021
Novavax to Participate in World Vaccine Congress Europe
- COVID-19
- Seasonal Influenza
Oct 15, 2021
Complete PREVENT-19 Phase 3 Clinical Trial Results Manuscript for COVID-19 Vaccine Posted to medRxiv
- Statement
- COVID-19
Oct 11, 2021

Show per page